TERAPET

terapet-logo

Terapet was founded at CERN by two physicists โ€“ Christina Vallgren and Marcus Palm โ€“ along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.

#SimilarOrganizations #People #Financial #Website #More

TERAPET

Social Links:

Industry:
Health Care Oncology

Founded:
2019-01-01

Address:
Geneva, Geneve, Switzerland

Country:
Switzerland

Website Url:
http://www.terapet.ch

Total Employee:
11+

Status:
Active

Total Funding:
6.25 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Google Maps Font Awesome Google Maps API WordPress 6.4 Google Maps For Work


Similar Organizations

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

cayaba-care-logo

Cayaba Care

Cayaba Care is a maternal health company that offers community-based clinical services.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

e-health-now-llc-logo

E-Health Now LLC

We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally, on a B2B model.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

immunitas-therapeutics-logo

Immunitas Therapeutics

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

odyssey-therapeutics-logo

Odyssey Therapeutics

Odyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.

oncora-medical-logo

Oncora Medical

Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.


Current Advisors List

giovanni-leo_image

Giovanni Leo Board Member @ Terapet
Board_member
2023-02-17

sebastian-anastassiou_image

Sebastian Anastassiou Board Member @ Terapet
Board_member
2023-02-17

Current Employees Featured

not_available_image

Raymond Miralbell
Raymond Miralbell Co-Founder, Chief Scientific Officer @ Terapet
Co-Founder, Chief Scientific Officer

marcus-palm_image

Marcus Palm
Marcus Palm Co-founder, CTO @ Terapet
Co-founder, CTO
2019-07-01

christina-vallgren_image

Christina Vallgren
Christina Vallgren Co-Founder, President, Chief Executive Officer @ Terapet
Co-Founder, President, Chief Executive Officer

Founder


christina-vallgren_image

Christina Vallgren

marcus-palm_image

Marcus Palm

not_available_image

Raymond Miralbell

Investors List

eurostars_image

Eurostars

Eurostars investment in Grant - Terapet

eurostars_image

Eurostars

Eurostars investment in Grant - Terapet

efi-lake-geneva-ventures_image

EFI Lake Geneva Ventures

EFI Lake Geneva Ventures investment in Seed Round - Terapet

nina-capital_image

Nina Capital

Nina Capital investment in Seed Round - Terapet

fongit-innovation-fund_image

FONGIT Innovation Fund

FONGIT Innovation Fund investment in Debt Financing - Terapet

nina-capital_image

Nina Capital

Nina Capital investment in Seed Round - Terapet

venturekick_image

Venture Kick

Venture Kick investment in Grant - Terapet

foundation-pour-l-innovation-technologique_image

Foundation for Technological Innovation (FIT)

Foundation for Technological Innovation (FIT) investment in Debt Financing - Terapet

masschallenge_image

MassChallenge

MassChallenge investment in Non Equity Assistance - Terapet

Official Site Inspections

http://www.terapet.ch Semrush global rank: 4.09 M Semrush visits lastest month: 2.55 K

  • Host name: sl1072.web.hostpoint.ch
  • IP address: 217.26.61.158
  • Location: Switzerland
  • Latitude: 47.1449
  • Longitude: 8.1551
  • Timezone: Europe/Zurich

Loading ...

More informations about "Terapet"

About โ€“ Terapet.ch

Terapet is a CERN MedTech spin-off and has developed an innovative platform technology: a novel gamma ray detection system for imaging in nuclear medicine. ... started with operational โ€ฆSee details»

Careers - Terapet.ch

Rue du Pré-Bouvier 7 1242 Satigny, Geneva Switzerland. NEWS. Read our latest updatesSee details»

Terapet SA - Venture Kick

Jun 5, 2024 Terapet SA: Terapet SA was incorporated in Geneva, Switzerland in December 2019, a CERN MedTech spin-off. ... 18.12.2023 Twenty-eight startups selected for the Innosuisse Scale up Coaching (startupticker.ch) ...See details»

Terapet SA - BioAlps

Organization Type . Private Company. Visit website Domains. Oncology . Main sector. Medtech ... [email protected] . BioAlps Association. Avenue de Sécheron 15 1202 Geneva, โ€ฆSee details»

Terapet SA - startup.ch

Terapet SA was incorporated in Geneva, Switzerland in December 2019, a CERN MedTech spin-off. The founders are Dr. Christina Vallgren (PhD in Applied Physics, MSc in Nuclear Physics and MBA), Dr. Marcus Palm (PhD in Applied โ€ฆSee details»

Terapet - Crunchbase Company Profile & Funding

Organization. Terapet . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Terapet is Improving Proton Therapy for Cancer โ€ฆSee details»

Terapet SA - startupticker.ch

Oct 13, 2023 Terapet envisions that its Qualyscanโ„ข and Claryscanโ„ข will enable QUALITY and CLARITY in every patientโ€™s diagnostic and treatment, making them the first choice for โ€ฆSee details»

Terapet | Knowledge Transfer - CERN

[email protected]. Media items. Read full article KT in the Media. Contact. CERN Esplanade des Particules 1 P.O. Box 1211 Geneva 23 Switzerland; Tel: +41 22 767 2623; โ€ฆSee details»

Interview with Christina Vallgren โ€“ W.A. de Vigier Stiftung

Terapet SA, a CERN startup, develops a novel medical device which enables medical doctors for the first time to monitor the delivered proton dose inside the patients during cancer treatment: in-vivo, non-invasive, in 3D and real-time. โ€ฆSee details»

Terapet closes seed financing round to advance the development โ€ฆ

The Swiss medtech startup Terapet raises CHF 1 million to support the development of its first full-scale prototype to be installed for clinical validation. TERAPET is a medtech startups โ€ฆSee details»

Terapet SA is proud to announce: Terapet together with their โ€ฆ

Terapet together with their clinical partners, ranked 2 out of 500 eligible projects across Europe by European Commission, receives a total of โ‚ฌ 700,000 non-dilutive grant financed by โ€ฆSee details»

Terapet SA - top100startup.ch

Nov 22, 2022 Terapet SA: Terapet SA was incorporated in Geneva, Switzerland in December 2019, a CERN MedTech spin-off. ... 22.01.2021 CHF1.5 million for making proton therapy โ€ฆSee details»

Terapet SA secures over CHF 2,3 million to bring its first ... - CERN

Feb 17, 2023 Read the original press release here.. Terapet, a privately held Swiss MedTech company developing next generation imaging technology, is pleased to announce the new โ€ฆSee details»

Terapet closes CHF 1 Million seed financing to advance the ... - CERN

CERN, the European Organization for Nuclear Research and has long been involved in the development of proton therapy. โ€œThis is a unique opportunity for Terapet to further advance โ€ฆSee details»

Terapet raises CHF 2.3 million for its next-generation cancer โ€ฆ

Feb 28, 2023 Geneva - Geneva-based medtech Terapet has announced the closing of its first Pre-Series A investment round in the amount of CHF 2.3 million. Terapet is a CERN start-up โ€ฆSee details»

Terapet SA together with their R&D partners are awarded EUR โ€ฆ

CERN, the European Organization for Nuclear Research, is one of the world's largest and most respected ... CH-1202 Geneva, Switzerland www.terapet.ch [email protected] Founders: Dr. โ€ฆSee details»

Terapet raises CHF 2.3 million for its next-generation cancer โ€ฆ

Feb 27, 2023 Geneva-based medtech Terapet has announced the closing of its first Pre-Series A investment round in the amount of CHF 2.3 million. Terapet is a CERN start-up that works โ€ฆSee details»

Terapet lève CHF 2,3 millions pour sa technologie innovante de ...

Feb 27, 2023 La société medtech genevoise Terapet a annoncé la clôture de son premier tour de table de pré-série A pour un montant de CHF 2,3 millions. Terapet est une start-up du โ€ฆSee details»

New partnership โ€“ Terapet SA and The Politecnico di Milano

Geneva, June 1 st, 2021 Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer, more precise, and time-saving proton therapy for cancer โ€ฆSee details»

linkstock.net © 2022. All rights reserved